|
1
|
Seikrit C, Rauen T and Floege J:
Immunoglobulin A nephropathy. Internist (Berl). 60:432–439. 2019.
View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Ebefors K, Liu P, Lassén E, Elvin J,
Candemark E, Levan K, Haraldsson B and Nyström J: Mesangial cells
from patients with IgA nephropathy have increased susceptibility to
galactose-deficient IgA1. BMC Nephrol. 17:402016. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Sanders JT, Hastings MC, Moldoveanu Z,
Novak J, Julian BA, Bursac Z and Wyatt RJ: Serial
galactose-deficient IgA1 levels in children with IgA nephropathy
and healthy controls. Int J Nephrol. 2017:82106412017. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Coppo R: Biomarkers and targeted new
therapies for IgA nephropathy. Pediatr Nephrol. 32:725–731. 2017.
View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Kim MJ, Schaub S, Molyneux K, Koller MT,
Stampf S and Barratt J: Effect of immunosuppressive drugs on the
changes of serum galactose-deficient IgA1 in patients with IgA
nephropathy. PLoS One. 11:e01668302016. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Lai KN, Tang SC, Schena FP, Novak J,
Tomino Y, Fogo AB and Glassock RJ: IgA nephropathy. Nat Rev Dis
Primers. 2:160012016. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Shin DH, Lim BJ, Han IM, Han SG, Kwon YE,
Park KS, Lee MJ, Oh HJ, Park JT, Han SH, et al: Glomerular IgG
deposition predicts renal outcome in patients with IgA nephropathy.
Mod Pathol. 29:743–752. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Ju T and Cummings RD: A unique molecular
chaperone Cosmc required for activity of the mammalian core 1 beta
3-galactosyltransferase. Proc Natl Acad Sci USA. 99:16613–16618.
2002. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Suzuki H, Yasutake J, Makita Y, Tanbo Y,
Yamasaki K, Sofue T, Kano T and Suzuki Y: IgA nephropathy and IgA
vasculitis with nephritis have a shared feature involving
galactose-deficient IgA1-oriented pathogenesis. Kidney Int.
93:700–705. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Placzek WJ, Yanagawa H, Makita Y, Renfrow
MB, Julian BA, Rizk DV, Suzuki Y, Novak J and Suzuki H: Serum
galactose-deficient-IgA1 and IgG autoantibodies correlate in
patients with IgA nephropathy. PLoS One. 13:e01909672018.
View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Sun Q, Zhang J, Zhou N, Liu X and Shen Y:
DNA methylation in Cosmc promoter region and aberrantly
glycosylated IgA1 associated with pediatric IgA nephropathy. PLoS
One. 10:e01123052015. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Serino G, Pesce F, Sallustio F, De Palma
G, Cox SN, Curci C, Zaza G, Lai KN, Leung JC, Tang SC, et al: In a
retrospective international study, circulating miR-148b and let-7b
were found to be serum markers for detecting primary IgA
nephropathy. Kidney Int. 89:683–692. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Serino G, Sallustio F, Cox SN, Pesce F and
Schena FP: Abnormal miR-148b expression promotes aberrant
glycosylation of IgA1 in IgA nephropathy. J Am Soc Nephrol.
23:814–824. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Livak KJ and Schmittgen TD: Analysis of
relative gene expression data using real-time quantitative PCR and
the 2(-Delta Delta C(T)) method. Methods. 25:402–408. 2001.
View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Schwartz GJ, Muñoz A, Schneider MF, Mak
RH, Kaskel F, Warady BA and Furth SL: New equations to estimate GFR
in children with CKD. J Am Soc Nephrol. 20:629–637. 2009.
View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Lee HS, Lee MS, Lee SM, Lee SY, Lee ES,
Lee EY, Park SY, Han JS, Kim S and Lee JS: Histological grading of
IgA nephropathy predicting renal outcome: Revisiting H. S. Lee's
glomerular grading system. Nephrol Dial Transplant. 20:342–348.
2005. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Runtsch MC, Hu R, Alexander M, Wallace J,
Kagele D, Petersen C, Valentine JF, Welker NC, Bronner MP, Chen X,
et al: MicroRNA-146a constrains multiple parameters of intestinal
immunity and increases susceptibility to DSS colitis. Oncotarget.
6:28556–28572. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Chandrasekaran K, Karolina DS, Sepramaniam
S, Armugam A, Wintour EM, Bertram JF and Jeyaseelan K: Role of
microRNAs in kidney homeostasis and disease. Kidney Int.
81:617–627. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Wang G, Kwan BC, Lai FM, Chow KM, Li PK
and Szeto CC: Elevated levels of miR-146a and miR-155 in kidney
biopsy and urine from patients with IgA nephropathy. Dis Markers.
30:171–179. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Pauley KM, Cha S and Chan EK: MicroRNA in
autoimmunity and autoimmune diseases. J Autoimmun. 32:189–194.
2009. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Bi Y, Liu G and Yang R: MicroRNAs: Novel
regulators during the immune response. J Cell Physiol. 218:467–472.
2009. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Pauley KM and Chan EK: MicroRNAs and their
emerging roles in immunology. Ann N Y Acad Sci. 1143:226–239. 2008.
View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Denby L and Baker AH: Targeting non-coding
RNA for the therapy of renal disease. Curr Opin Pharmacol.
27:70–77. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Lai JY, Luo J, O'Connor C, Jing X, Nair V,
Ju W, Randolph A, Ben-Dov IZ, Matar RN, Briskin D, et al:
MicroRNA-21 in glomerular injury. J Am Soc Nephrol. 26:805–816.
2015. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Serino G, Sallustio F, Curci C, Cox SN,
Pesce F, De Palma G and Schena FP: Role of let-7b in the regulation
of N-acetylgalactosaminyltransferase 2 in IgA nephropathy. Nephrol
Dial Transplant. 30:1132–1139. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Denby L, Ramdas V, Lu R, Conway BR, Grant
JS, Dickinson B, Aurora AB, McClure JD, Kipgen D, Delles C, et al:
MicroRNA-214 antagonism protects against renal fibrosis. J Am Soc
Nephrol. 25:65–80. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Yeo SC, Cheung CK and Barratt J: New
insights into the pathogenesis of IgA nephropathy. Pediatr Nephrol.
33:763–777. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Mao S, Xuan X, Sha Y, Zhao S, Zhu C, Zhang
A and Huang S: Clinico-pathological association of
Henoch-Schoenlein purpura nephritis and IgA nephropathy in
children. Int J Clin Exp Pathol. 8:2334–2342. 2015.PubMed/NCBI
|
